Pediatric Neurosurgery
Original Paper
Late Shunt InfectionsBaird C.b · O’Connor D.a · Pittman T.bDivisions of aPediatrics and bNeurological Surgery, Cardinal Glennon Children’s Hospital, St. Louis, Mo., USA
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Published online: February 17, 2000
Issue release date: November 1999
Number of Print Pages: 5
Number of Figures: 1
Number of Tables: 2
ISSN: 1016-2291 (Print)
eISSN: 1423-0305 (Online)
For additional information: https://www.karger.com/PNE
Abstract
We reviewed the records of the 957 shunt-related operations performed at Cardinal Glennon Children’s Hospital over a 10-year period. During that time, 94 shunt infections were recognized. Eight of the infections occurred more than 9 months postoperatively. These differed from early infections in two ways: (1) Staphylococcus aureus was not found to be a pathogen in any late infection. (2) Abdominal pseudocysts were much more frequently found in patients with late-developing infections. In addition, the pathogens involved and the temporal distribution of cases suggest most infections that occur more than 9 months postoperatively are more likely caused by secondary bacterial seeding than by bacterial inoculation at the time of operation.
© 2000 S. Karger AG, Basel
Related Articles:
References
-
Bayston R, Lari J: A study of the sources of infection in colonised shunts. Dev Med Child Neurol 1974;16(suppl 32):16–22.
- McLaurin RL, Frame PT: Treatment of infections of cerebrospinal fluid shunts. Rev Infect Dis 1987;9:595–603.
- Odio C, McCracken GH Jr, Nelson JD: CSF shunt infections in pediatrics: A seven year experience. Am J Dis Child 1984;138:1103–1108.
- Reiner D, Lacombe J, Pierre-Kahn A, Sainte-Rose C, Hirsch JF: Factors causing acute shunt infection. J Neurosurg 1984;61:1072–1078.
- Schoenbaum SD, Gardner P, Shillito J: Infections of cerebrospinal fluid shunts: Epidemiology, clinical manifestations, and therapy. J Infect Dis 1975;131:543–552.
- Vanaclocha V, Sáiz-Sapena N, Leiva J: Shunt malfunction in relation to shunt infection. Acta Neurochir (Wien) 1996;138:829–834.
- George R, Leibrock L, Epstein M: Long-term analysis of cerebrospinal fluid shunt infections. J Neurosurg 1979;51:804–811.
- Roitberg BZ, Tomita T, McLone DG: Abdominal cerebrospinal fluid pseudocyst. A complication of ventriculoperitoneal shunt in children. Pediatr Neurosurg 1998;29:267–273.
- Schiff SJ, Oakes WJ: Delayed cerebrospinal-fluid shunt infection in children. Pediatr Neurosci 1989;15:131–135.
- Shapiro S, Boaz J, Kleiman M, Kalsbeck J, Mealey J: Origin of organisms infecting ventricular shunts. Neurosurgery 1988;22:868–872.
- Gaskill SJ, Marlin AE: Spontaneous bacterial peritonitis in patients with ventriculoperitoneal shunts. Pediatr Neurosurg 1997;26:115–119.
- Zierdt CH: Evidence for transient Staphylococcus epidermidis bacteremia in patients and in healthy humans. J Clin Microbiol 1983;17:628–630.
- Piatt JH Jr: Cerebrospinal fluid shunt failure: Late is different from early. Pediatr Neurosurg 1995;23:133–139.
- Erşahin Y, Mutluer S, Tekeli G: Abdominal cerebrospinal fluid pseudocysts. Childs Nerv Syst 1996;12:755–758.
- Parry SW, Schumacher JF, Llewellyn RC: Abdominal pseudocyst and ascites formation after ventriculoperitoneal shunt procedures: Report of four cases. J Neurosurg 1975;43:476–479.
- Jimenez DF, Keating R, Goodrich JT: Silicone allergy in ventriculoperitoneal shunts. Childs Nerv Syst 1994;10:59–63.
- Pittman T, Williams D, Rathore M, Knutsen AP, Mueller KR: The role of ethylene oxide allergy in sterile shunt malfunctions. Br J Neurosurg 1994;8:41–45.
Article / Publication Details
Published online: February 17, 2000
Issue release date: November 1999
Number of Print Pages: 5
Number of Figures: 1
Number of Tables: 2
ISSN: 1016-2291 (Print)
eISSN: 1423-0305 (Online)
For additional information: https://www.karger.com/PNE
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Get Permission
PubMed ID
